Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02427737 · ClinicalTrials.gov registry record · NA

Comfort Talk and Economic Outcomes in MRI

A NA study of Claustrophobia and Complication of Diagnostic Procedure, sponsored by Hypnalgesics.

Completed
Registry status
NA
Development phase
12
Enrollment target
3
Study locations

NCT02427737 is a NA study of Claustrophobia and Complication of Diagnostic Procedure that has completed, run by Hypnalgesics. The registered enrollment target is 12 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02427737, a NA study of Claustrophobia and Complication of Diagnostic Procedure, has completed, sponsored by Hypnalgesics.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
3
Study locations

Study Summary

Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staffs working in MRI facilities to provide Comfort Talk® will enable patients to complete high quality imaging without medication, which will increase satisfaction and comfort while reducing sedation risks for patients, and increase efficiency and reduce loss of revenue for facilities. The effect of such training will be tested at 12 MRI sites in a randomized design. Outcome data will be collected for one year.

Interventions

  • BEHAVIORAL Comfort Talk® Training

Study Locations (3)

Massachusetts

  • Hypnalgesics, LLC - Brookline

North Carolina

  • Duke University Medical Center - Durham

Ohio

  • Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-04
Est. Completion 2017-07-31
Phase NA

Sponsor

Hypnalgesics

3 total trials

What the Registry Record Tells You About NCT02427737

The ClinicalTrials.gov registry entry for NCT02427737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hypnalgesics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Claustrophobia appearing as the primary indexed condition, and to 1 intervention - of which Comfort Talk® Training is the first listed.

NCT02427737 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT02427737 about?

NCT02427737 is a clinical study titled "Comfort Talk and Economic Outcomes in MRI". Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staffs working in MRI facilities to provide Comfort Talk® will enable patients to complete high quality imaging without medication, which will increase sat...

What is the current status of trial NCT02427737?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2017-07-31.

What conditions does trial NCT02427737 study?

This clinical trial studies the following conditions: Claustrophobia, Complication of Diagnostic Procedure.

What interventions are being tested in trial NCT02427737?

The interventions under investigation include: Comfort Talk® Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02427737?

This trial is sponsored by Hypnalgesics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02427737 being conducted?

This trial has 3 study locations across Massachusetts, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Claustrophobia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.